Xtant Medical Holdings, Inc. reported its financial results for the third quarter of 2026 on November 16, 2026. This announcement is significant as it provides insights into the company's operational performance and future outlook.

Xtant Medical Holdings, Inc. operates in the surgical and medical instruments and apparatus sector, as indicated by its Standard Industrial Classification (SIC) code of 3841. The company is traded on the NYSE under the ticker symbol XTNT. As a smaller reporting company, it has been active in filing various reports, including its recent 8-K submissions.

According to the filing, "On November 16, 2026, Xtant Medical Holdings, Inc. announced its financial results for the third quarter of 2026." The full text of the press release related to these results is included as Exhibit 99.1 in the filing.

The impact of these results may affect various stakeholders, including investors, analysts, and competitors in the surgical and medical instruments industry. The financial performance reported could influence investor confidence and the company's strategic direction moving forward.

The filing does not specify what happens next regarding future announcements or strategic initiatives following this report.

The filing also highlights that Xtant Medical Holdings, Inc. utilizes non-GAAP financial measures, such as non-GAAP adjusted EBITDA, to supplement its consolidated financial statements. This measure is defined as net income (loss) from operations before depreciation, amortization, interest expense, and tax benefit, adjusted for non-cash compensation and other special items. The company believes that this measure provides meaningful insights into its core operational performance, aiding in budgeting and resource allocation decisions.

Furthermore, the company excludes certain items from its non-GAAP adjusted EBITDA, including non-cash compensation related to equity awards, unrealized foreign currency translation gains or losses, and the write-off of distribution agreement deposits. These exclusions are made to present a clearer picture of the company's ongoing operational results, which management believes are more reflective of its core profitability.

The filing does not include specific numerical financial results or comparisons to previous quarters, which could provide a clearer context for evaluating the company's performance.